Endurant Capital Management’s ADC Therapeutics ADCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-58,967	Closed	-$469K	–	51
2022 Q2	$469K	Buy	+58,967	New	+$469K	0.16%	43
2020 Q4	–	Sell	-12,000	Closed	-$396K	–	53
2020 Q3	$396K	Buy	12,000 +7,590	+172%	+$250K	0.12%	55
2020 Q2	$206K	Buy	+4,410	New	+$206K	0.01%	54